Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Renal Artery Denervation Feasibility Study of the MetAvention Integrated Radio Frequency Denervation System for the Treatment of Hypertension

NCT04740723 is registered in ClinicalTrials.gov with Metavention as lead sponsor.

NCT NCT04740723
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04740723 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Renal Artery Denervation Feasibility Study of the MetAvention Integrated Radio Frequency Denervation System for the Treatment of Hypertension
Lead sponsor
Metavention
Phase
Not applicable
Overall status
Completed
Start date
February 6, 2021
Completion date
October 13, 2022
Enrollment
30 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension, metabolic syndrome